oxybutynin has been researched along with Kidney Failure, Chronic in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty patients with ESRD were treated with Qutenza® for neuropathic pain from critical limb ischemia." | 5.46 | The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study. ( Aitken, E; Kingsmore, D; McColl, G, 2017) |
| "Twenty patients with ESRD were treated with Qutenza® for neuropathic pain from critical limb ischemia." | 1.46 | The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study. ( Aitken, E; Kingsmore, D; McColl, G, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsai, MY | 1 |
| Su, YJ | 1 |
| Ng, HY | 1 |
| Chen, SY | 1 |
| Huang, YC | 1 |
| Wu, CH | 1 |
| Chen, YH | 1 |
| Aitken, E | 1 |
| McColl, G | 1 |
| Kingsmore, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Department of Traditional Chinese Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung[NCT02210377] | Phase 2 | 45 participants (Anticipated) | Interventional | 2015-03-31 | Recruiting | ||
| A Randonimised Trial Comparing Interrupted to Continuous Suturing Techniques in Radiocephalic Fistulae[NCT01704313] | 70 participants (Anticipated) | Interventional | 2012-05-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for oxybutynin and Kidney Failure, Chronic
| Article | Year |
|---|---|
Study protocol for a single-blind, placebo-controlled randomised trial of Tianjiu effects in patients with intradialytic hypotension.
Topics: Adult; Aged; Blood Pressure; Fatigue; Female; Humans; Hypotension; Kidney Failure, Chronic; Male; Mi | 2016 |
1 other study available for oxybutynin and Kidney Failure, Chronic
| Article | Year |
|---|---|
The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study.
Topics: Administration, Topical; Adult; Aged; Capsaicin; Cohort Studies; Female; Humans; Ischemia; Kidney Fa | 2017 |